Coupled with an expanded programmatic focus on the tumor microenvironment, the continued development and translation of novel immunotherapies will accelerate.
The MOO research program aims to understand how normal cells undergo complex changes leading to cancer.
The goal of the statewide program is to support innovative cancer research and treatment models.
Recent UF Health Cancer Institute publications.
Erin Mobley, Ph.D., is the first author of a new study finding that the heart-protective drug dexrazoxane significantly reduced chemotherapy-related heart damage for years after treatment.
UF Health Shands Hospital is ranked No. 35 in the nation for cancer.
By providing training in basic and translational cancer research, the internship aims to prepare the next generation of researchers for success.Â
Researchers created a drug that effectively kills aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
With a Florida Department of Health grant, Ibrahim Nassour, M.D., is leading a collaboration that aims to improve gastric cancer care outcomes.
The Office of Community Outreach and Engagement submitted a report to the state of Florida describing findings on the needs of cancer survivors and caregivers.
